ODAIA 完成 1500 万美元 C 轮融资,扩展制药商业智能平台
ODAIA Raises $15M, Scaling Predictive Pharma Commercial Intelligence Across Enterprise Portfolios
制药行业的销售预测工具拿了 1500 万美元继续扩张。它跟一般 CRM 的区别是能把处方数据、代表拜访记录和线上互动拼成每个医生的完整画像,而且模型跨产品复用。做药企数字化或者医药营销的朋友可以看看。
ODAIA 宣布完成 1500 万美元 C 轮融资,投资方包括 Monograph Capital 和 PHM Exclusive Agency Partner,资金用于扩展其面向制药企业的预测性商业智能平台。
平台的核心是一套组合级全渠道架构,包含 Brand Strategy Studio、Field Intelligence 和 Marketing Intelligence 三个模块,将分散的处方数据、医药代表销售活动和数字互动信号整合为每位医生的单一定向长期视图。与传统做法需要数据科学团队为每个产品单独重建模型不同,ODAIA 让同一套预测模型可以跨整个产品组合复用,降低每个品牌的部署成本。
这一融资反映出制药营销自动化赛道正从单品牌工具向企业级平台演变,对于管理多条产品线的药企而言,跨品牌复用 AI 模型是比逐品牌采购更经济的路径。
ODAIA Raises $15M, Scaling Predictive Pharma Commercial Intelligence Across Enterprise Portfolios
What You Should Know Portfolio-Scale Omnichannel Architecture: Brand Strategy Studio, Field Intelligence, and Marketing Intelligence ODAIA’s platform establishes a unified commercial intelligence foundation that integrates disparate prescribing data, field sales activity, and digital engagement signals into a single longitudinal view of each physician. Rather than requiring data science teams to rebuild models for every product ... Read More
This report is categorized under AITOP's "Products" desk. Key entities and technical topics under continuous tracking include ODAIA, pharmaceuticals, business intelligence, funding.
Source attribution: curated from HIT Consultant (@Jasmine Pennic).